Obseva Sa (OBSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OBSV | AMGN | VRTX | REGN | GSK |
| Company | Obseva Sa | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.1235 | 306.42 | 451.90 | 984.04 | 45.42 |
| High | 0.1235 | 307.39 | 456.17 | 988.77 | 45.45 |
| Low | 0.1000 | 303.90 | 449.42 | 983.16 | 45.15 |
| Last | 0.1018 | 306.46 | 456.70 | 988.00 | 45.19 |
| Change | -0.0187 | -0.04 | +5.90 | +7.43 | +0.04 |
| % Change | -15.52% | -0.01% | +1.31% | +0.76% | +0.09% |
| Volume | 8,230,800 | 277,833 | 233,846 | 48,066 | 573,772 |
| 20-Day Average Volume | 23,680,555 | 2,759,090 | 1,120,018 | 414,295 | 3,846,762 |
| Previous Close | 0.1205 | 306.50 | 450.80 | 980.57 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1357 | 303.14 | 424.41 | 961.42 | 44.28 |
| 20-Day Raw Stochastic | 10.56% | 65.30% | 97.43% | 89.15% | 84.13% |
| 20-Day Relative Strength | 41.52% | 56.38% | 73.53% | 60.01% | 62.75% |
| Weighted Alpha | -68.10 | +35.81 | +39.78 | +35.13 | +35.59 |
| Today's Opinion | 88% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.63% since 03/15/23 | -2.71% since 05/17/24 | +2.09% since 05/17/24 | +0.32% since 05/17/24 | +0.51% since 05/17/24 |
| Low | 0.1000 on 03/22/23 | 303.99 on 05/24/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 44.40 on 05/20/24 |
| High | 0.1347 on 03/17/23 | 316.67 on 05/21/24 | 456.17 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -41.80% since 02/22/23 | +11.35% since 04/24/24 | +13.41% since 04/24/24 | +8.70% since 04/24/24 | +10.65% since 04/24/24 |
| Low | 0.0800 on 02/24/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.81 on 04/25/24 |
| High | 0.2865 on 03/03/23 | 322.60 on 05/03/24 | 456.17 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -30.80% since 12/22/22 | +5.12% since 02/23/24 | +5.67% since 02/23/24 | +0.43% since 02/23/24 | +7.08% since 02/23/24 |
| Low | 0.0800 on 02/24/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 0.2865 on 03/03/23 | 322.60 on 05/03/24 | 456.17 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -30.75% since 09/22/22 | +14.52% since 11/24/23 | +28.74% since 11/24/23 | +23.44% since 11/24/23 | +26.25% since 11/24/23 |
| Low | 0.0800 on 02/24/23 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 0.2865 on 03/03/23 | 329.72 on 02/05/24 | 456.17 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,937 | 164,417,328 | 116,330,288 | 108,045,080 | 93,570,672 |
| Shares Outstanding, K | 77,971 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 20,110,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -58,380,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 3,710,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -12,060,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.68 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 12/01/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 03/23/23 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 29.72 | 26.51 | 11.33 |